Theriva Biologics's market cap is currently $4.48M. The company's EPS TTM is $-33.057; its P/E ratio is ―; Theriva Biologics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-7.22. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -135.00K	$ -268.00K	$ -87.00K	$ -201.00K	$ -240.00K
Operating Income	$ -21.43M	$ -21.58M	$ -14.27M	$ -10.16M	$ -15.66M
EBITDA	$ -19.85M	$ -21.58M	$ -14.19M	$ -9.96M	$ -15.42M
Net Income	$ -18.35M	$ -19.68M	$ -14.17M	$ -10.00M	$ -15.02M
Balance Sheet
Cash & Short-Term Investments	$ 23.18M	$ 41.79M	$ 67.33M	$ 6.23M	$ 15.04M
Total Assets	$ 55.22M	$ 71.86M	$ 70.36M	$ 8.41M	$ 17.23M
Total Debt	$ 2.15M	$ 1.68M	$ 1.53M	$ 473.00K	$ 722.00K
Net Debt	$ -21.02M	$ -40.10M	$ -65.80M	$ -5.75M	$ -14.32M
Total Liabilities	$ 15.52M	$ 17.30M	$ 4.96M	$ 3.15M	$ 5.75M
Stockholders' Equity	$ 39.70M	$ 54.56M	$ 65.41M	$ 8.03M	$ 14.37M
Cash Flow
Free Cash Flow	$ -19.20M	$ -19.20M	$ -12.90M	$ -12.18M	$ -13.87M
Operating Cash Flow	$ -19.00M	$ -19.08M	$ -12.89M	$ -12.17M	$ -13.87M
Investing Cash Flow	$ -202.00K	$ -4.40M	$ -14.00K	$ -9.00K	$ 0.00
Financing Cash Flow	$ 625.00K	$ -1.93M	$ 74.00M	$ 3.36M	$ 0.00

Currency in USD

Theriva Biologics Earnings and Revenue History

Income Statement >

Theriva Biologics Debt to Assets

Balance Sheet >

Theriva Biologics Cash Flow

Cash Flow >

Theriva Biologics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing